Treatment of the elderly patient with acute myeloid leukaemia

Bailliere's Clinical Haematology

Volumn 9, Issue 1, 1996, Pages 147-159

  Lowenberg, B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DAUNORUBICIN; HEMOPOIETIC GROWTH FACTOR; MITOXANTRONE; TIOGUANINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; CANCER COMBINATION CHEMOTHERAPY; HUMAN; LEUKEMIA REMISSION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT OUTCOME;

EID: 0029981308     PISSN: 09503536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3536(96)80041-2     Document Type: Article

References (44)

1. Arceci RJ Clinical significance of P-glycoprotein in multidrug resistance malignancies Blood 81 1993 2215 2222
2. Arlin Z Case DC Moore J Randomised multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL) Leukemia 4 1990 177 183
3. Balducci L Parker M Sexton W Tantranond P Pharmacology of antineoplastic agents in the elderly patient Seminars in Oncology 16 1989 76 84
4. Baudard M Marie JP Cadiou M Acute myelogenous leukemia in the elderly: retrospective study of 235 consecutive patients British Journal of Haematology 86 1994 82 91
5. Bettelheim P Valent P Andreeff M Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia Blood 77 1991 700 711
6. Bhalla K Birkhofer M Arlin Z Effect of recombinant GM-CSF on the metabolism of cytosine arabinoside in normal and leukemic human bone marrow cells Leukemia 2 1988 810 813
7. Boekhorst PAW te Löwenberg B Sonneveld P Stimulation by granulocyte colony stimulating factor (G-CSF), interleukin-3 (IL-3) or granulocyte-macrophage colony stimulating factor (GM-CSF) enhances chemosensitivity by clonogenic acute myeloid leukemia cells Blood 80 1992 432
8. Boekhorst PAW te Leeuw K de Schoester M Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells Blood 82 1993 3157 3162
9. Boekhorst PAW te Sonneveld P Löwenberg B Autonomous growth and drug resistance mechanisms in adult acute myeloid leukemia Experimental Hematology 21 1993 250
10. Boekhorst PAW te Löwenberg B Sonneveld P Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia Leukemia 8 1994 1480 1486
11. Boggs DR Patrene KD Hematopoiesis and aging III: Anemia and a blunted erythropoietic response to hemorrhage in aged mice American Journal of Hematology 19 1985 327 338
12. Brinker H Population-based age and sex specific incidence rates in the 4 main types of leukemia Scandinavian Journal of Haematology 29 1982 241 249
13. Brinker H Estimate of overall treatment results in acute non-lymphocytic leukemia based on age specific rates of incidence and complete remission Cancer Treatment Reports 69 1985 5 11
14. Büchner Th Hiddemann W Koenigsmann M Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse Blood 78 1991 1190 1197
15. Cahn JY Labopin M Mandelli F Autologous bone marrow transplantation for first remission acute myeloblastic leukemia in patients older than 50 years: a retrospective analysis of the European Bone Marrow Transplant Group Blood 85 1995 575 579
16. Campos L Rouault JP Sabido O High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy Blood 81 1993 3091 3096
17. Cannistra SA Groshek P Griffin JD Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3 1989 328 334
18. Dastugue N Payen C Lafage-Pochitaloff M Prognostic significance of karyotype in de novo adult acute myeloid leukemia Leukemia 9 1995 1491 1498
19. Dombret H Chastang C Fenaux P A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia New England Journal of Medicine 332 1995 1678 1683
20. Geller RB Zahurak M Hurwitz CA Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My 10) British Journal of Haematology 76 1990 340 347
21. Guinot M Sanz GF Sempere A Prognostic value of CD34 expression in de novo acute myeloblastic leukemia British Journal of Haematology 15 1991 533 534
22. Hiddemann W Kiehl M Zühlsdorf M Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemia blasts and the cytotoxic effect of clonogenic cells from patients with acute myeloid leukemia Seminars in Oncology 19 1992 31 37
23. Kahn SB Begg CB Mazza JJ Full dose versus attenuated dose daunomycin, cytosine arabinoside and 6-thio-guanine in the treatment of acute nonlymphocytic leukemia in the elderly Journal of Clinical Oncology 2 1984 865 870
24. Keating MJ Mc. Credie KB Benjamin RS Treatment of patients over 50 years of age with acute myelogenous leukemia with a combination of rubidizone and cytosine arabinoside, vincristine and prednisone (ROAP) Blood 58 1981 584 590
25. Lamy T Goasguen JE Mordelet E P-Glycoprotein (P-170) and CD34 Expression in adult acute myeloid leukemia (AML) Leukemia 11 1994 1879 1883
26. Liu Yin JA Acute myeloid leukaemia in the elderly: biology and treatment British Journal of Haematology 83 1993 1 6
27. Liu Yin JA Johnson PRE Davies JM Mitozantrone and cytosine arabinoside as first-line therapy in elderly patients with acute myeloid leukemia British Journal of Haematology 79 1991 415 420
28. Löwenberg B Zittoun R Kerkhofs H On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the EORTC Leukemia Group Journal of Clinical Oncology 1 1989 1268 1274
29. Löwenberg B Touw IP Hematopoietic growth factors and their receptors in acute leukemia Blood 81 1993 281 292
30. Löwenberg B Putten WLJ van Touw IP Autonomous proliferation of leukemia cells in vitro as a determinant of prognosis in adult acute myeloid leukemia New England Journal of Medicine 328 1993 614 619
31. (abstract) Löwenberg B Suciu S Zittoun R GM-CSF during as well as after induction chemotherapy (CT) in elderly patients with acute myeloid leukemia (AML). The EORTC-HOVON phase III trial (AML 11) Blood 86 supplement 10 1995 43
32. Mayer RJ Davis RB Schiffer CA Intensive postremission chemotherapy in adults with acute myeloid leukemia New England Journal of Medicine 331 1994 896 903
33. Miyauchi J Kelleher CA Wang CH Growth factors influence the sensitivity of leukemic stem cells to cytosine arabinoside in culture Blood 73 1989 1272 1278
34. Ohno R Naoe T Kanamaru A A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia Blood 83 1994 2086 2092
35. (abstract) Ossenkoppele GJ Verhoef GEG Bolt B v.d. Randomized phase II study on the value of G-CSF (filgrastim) in combination with standard induction chemotherapy in myclodysplastic syndromes (MDS) Blood 86 supplement 1 1995 338a
36. Rees JKH Gray RG Swirsky D Hayhoe FGJ Principal results of the medical research council's 8th acute myeloid leukemia trial Lancet ii 1986 1236 1241
37. Rees JKH Gray R Comparison of 1 + 5 DAT and 3 + 10 DAT followed by COAP or MAZE consolidation therapy in the treatment of acute myeloid leukemia: MRC ninth AML trial Seminars in Oncology 14 1987 32 36
38. Rowe JM Andersen JW Mazza JJ A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E 1490) Blood 86 1995 457 462
39. Santini V Nooter K Delwel R Löwenberg B Susceptibility of acute myeloid leukemia (AML) cells from clinically resistant and sensitive patients to daunomycin (DNR): assessment in vitro after stimulation with colony stimulating factors (CSFs) Leukemia Research 14 1990 377 380
40. Solary E Casanovas RE Campos L Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR- phenotypes with shorter survival Leukemia 6 1992 393 399
41. Stasi R Poeta GD Venditti A Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0) Blood 83 1994 1619 1625
42. Stone RM Berg DT George SL Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia New England Journal of Medicine 332 1995 1671 1677
43. Williams LH Udupa KB Lipschitz DA Evaluation of the effect of hematopoiesis in C57BL/6 mouse Experimental Hematology 14 1986 827 832
44. Yates J Glidewell O Wiernik P Cytosine arabinoside with daunomycin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study Blood 60 1982 454 463